Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples.

ABSTRACT: Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples.

PROVIDER: PRJNA510124 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8321170_1.fastq.gz	Fastqsanger.gz
	SRR8321170_2.fastq.gz	Fastqsanger.gz
	SRR8321180_1.fastq.gz	Fastqsanger.gz
	SRR8321180_2.fastq.gz	Fastqsanger.gz
	SRR8321171_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for glioblastoma stem cell

Project description:Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for glioblastoma stem cell

| PRJNA678319 | ENA

Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for glioblastoma stem cell

Project description:In human, the 39 coding HOX genes and 18 referenced non-coding antisense transcripts are arranged in four genomic clusters named HOXA, B, C, and D. This highly conserved family belongs to the homeobox class of genes that encode transcription factors required for normal development. Therefore, HOX gene deregulation might contribute to the development of many cancer types. Here, we study HOX gene deregulation in adult glioma, a common type of primary brain tumor. We performed extensive molecular analysis of tumor samples, classified according to their isocitrate dehydrogenase (IDH1) gene mutation status, and of glioma stem cells. We found widespread expression of sense and antisense HOX transcripts only in aggressive (IDHwt) glioma samples, although the four HOX clusters displayed DNA hypermethylation. Integrative analysis of expression-, DNA methylation- and histone modification signatures along the clusters revealed that HOX gene upregulation relies on canonical and alternative bivalent CpG island promoters that escape hypermethylation. H3K27me3 loss at these promoters emerges as the main cause of widespread HOX gene upregulation in IDHwt glioma cell lines and tumors. Our study provides the first comprehensive description of the epigenetic changes at HOX clusters and their contribution to the transcriptional changes observed in adult glioma. It also identified putative "master" HOX proteins that might contribute to the tumorigenic potential of glioma stem cells.

2021-03-09 | GSE161438 | GEO

Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples.

Project description:Aberrant DNA methylation is a well-defined feature of cancer cells that is commonly associated to transcriptional alteration. Nonetheless, a primary role of this defect in genome-wide cancer-associated gene misregulation is still being questioned. Here, we used adult glioma, a widespread type of brain tumor, to evaluate the relative contribution of DNA methylation-dependent and -independent mechanisms on transcriptional alteration at CpG-island/promoter-associated genes in cancer cells. By extensive molecular analyses conducted in both IDH wild-type (IDHwt) and IDH mutated (IDHmut) samples, we show that DNA hypermethylation affects only a minority of genes that show a loss or a gain of expression. In IDHwt samples, for instance, more than 75% of aberrantly repressed genes do not display DNA methylation defect at their CpG-island promoter. Rather, an alteration in the H3K27me3 signature is the predominant molecular defect at misregulated genes. We also observed that a bivalent chromatin signature in stem cell might not only predispose genes to hypermethylation, as widely documented, but more generally to all type of transcriptional alterations. In addition, we evidenced that transcriptional strength in healthy brain influences the choice between DNA methylation- or H3K27me3- associated silencing pathway at repressed genes in glioma. Combined our study supports a model whereby the altered developmental control of H3K27me3 dynamics, and more specifically defects in the interplay between polycomb protein complexes and brain-specific transcriptional machinery, is the main cause of transcriptional alteration in glioma cells. Together our study provides a comprehensive and revisited picture of epigenetic gene deregulations in cancer. Our observations are also of importance for the design of drugs that aims to target cancer epigenetic defects.

2019-09-09 | GSE123892 | GEO

Ribo-Seq performed in parental or CPEB4 knock-out HeLa cells

Project description:Ribo-Seq performed in parental or CPEB4 knock-out HeLa cells

| PRJNA779948 | ENA

kit

Project description:Xenopus tropicalis kit, KIT proto-oncogene receptor tyrosine kinase [Source:NCBI gene;Acc:100216090], is differentially expressed in 1 experiment(s);

| ENSXETG00000021049 | ExpressionAtlas

kit

Project description:Xenopus tropicalis kit, KIT proto-oncogene receptor tyrosine kinase [Source:NCBI gene;Acc:100216090], is expressed in 1 baseline experiment(s);

| ENSXETG00000021049 | ExpressionAtlas

Kit

Project description:Rattus norvegicus Kit, KIT proto-oncogene receptor tyrosine kinase [Source:RGD Symbol;Acc:620568], is expressed in 6 baseline experiment(s);

| ENSRNOG00000002227 | ExpressionAtlas

Kit

Project description:Rattus norvegicus Kit, KIT proto-oncogene receptor tyrosine kinase [Source:RGD Symbol;Acc:620568], is differentially expressed in 25 experiment(s);

| ENSRNOG00000002227 | ExpressionAtlas

KIT

Project description:Monodelphis domestica KIT, KIT proto-oncogene, receptor tyrosine kinase [Source:NCBI gene;Acc:100017501], is expressed in 2 baseline experiment(s);

| ENSMODG00000020671 | ExpressionAtlas

KIT

Project description:Sus scrofa KIT, KIT proto-onco, receptor tyrosine kinase [Source:VGNC Symbol;Acc:VGNC:98060], is differentially expressed in 4 experiment(s);

| ENSSSCG00000008842 | ExpressionAtlas

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data